Capitalization 7.69B 2.05B 1.75B 1.62B 1.52B 2.84B 187B 3.04B 18.7B 7.39B 88.76B 7.53B 324B P/E ratio 2025 *
26.4x
P/E ratio 2026 * 20.3x
Enterprise value 8.44B 2.25B 1.92B 1.78B 1.67B 3.11B 205B 3.34B 20.52B 8.11B 97.42B 8.27B 356B EV / Sales 2025 *
2.72x
EV / Sales 2026 * 2.48x
Free-Float
22.77%
Yield 2025 *
0.87%
Yield 2026 * 0.79%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.72%
1 week-0.06%
Current month-1.94%
1 month-4.73%
3 months-20.08%
6 months-14.56%
Current year-1.94%
More quotes
1 week 33.02
Extreme 33.02
34.08
1 month 33.02
Extreme 33.02
35.52
Current year 33.02
Extreme 33.02
34.38
1 year 33.02
Extreme 33.02
70.5
3 years 33.02
Extreme 33.02
72.9
5 years 33.02
Extreme 33.02
72.9
10 years 33.02
Extreme 33.02
72.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 2011-12-31
Director of Finance/CFO 60 2020-12-07
Director TitleAgeSince
Director/Board Member 73 2021-06-19
Director/Board Member 62 2021-06-19
Chairman 62 2011-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.72%-0.06%-50.97% - 2.04B
0.00%-1.64%+17.62%+40.40% 18.33B
-2.49%-0.35%-8.37%-56.56% 15.12B
-3.09%-4.90%+1.94%+60.08% 11.29B
-1.65%+0.31%+28.06%+91.53% 10.39B
-1.73%-1.42%+3.23%+57.75% 10.11B
+3.08%+11.05%-14.83%-33.55% 9.93B
-0.78%-0.39%-29.28% - 7.8B
-3.99%-4.13%+31.06%+199.51% 7.41B
+0.08%+2.06%+7.41%-45.85% 5.66B
Average -0.98%+0.90%-1.41%+39.16% 9.81B
Weighted average by Cap. -1.12%+0.61%+3.41%+33.82%
See all sector performances

Financials

2025 *2026 *
Net sales 3.11B 828M 706M 654M 615M 1.14B 75.36B 1.23B 7.55B 2.98B 35.84B 3.04B 131B 3.63B 967M 824M 764M 718M 1.34B 88.02B 1.43B 8.82B 3.48B 41.85B 3.55B 153B
Net income 277M 73.81M 62.91M 58.29M 54.82M 102M 6.72B 109M 673M 266M 3.19B 271M 11.66B 382M 102M 86.72M 80.35M 75.57M 141M 9.26B 151M 927M 366M 4.4B 374M 16.07B
Net Debt 751M 200M 171M 158M 149M 277M 18.22B 297M 1.83B 721M 8.67B 735M 31.62B 1.31B 349M 297M 276M 259M 482M 31.75B 517M 3.18B 1.26B 15.1B 1.28B 55.1B
More financial data * Estimated data
Logo Dr. Soliman Abdel Kader Fakeeh Hospital Company
Dr. Soliman Abdel Kader Fakeeh Hospital Company SCJSC is a Saudi Arabia-based company engaged in operating private hospitals and clinics. It offers its medical services through six units: Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.
Employees
2,672
More about the company
Date Price Change Volume
26-01-20 33.44 +0.72% 155,741
26-01-19 33.20 -0.42% 141,457
26-01-18 33.34 +0.91% 95,166
26-01-15 33.04 -2.48% 173,257
26-01-14 33.88 +0.41% 208,437

Delayed Quote Saudi Arabian S.E., January 20, 2026 at 07:20 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
33.44SAR
Average target price
43.74SAR
Spread / Average Target
+30.80%
Consensus

Quarterly revenue - Rate of surprise